Regine W F, Scott C, Murray K, Curran W
University of Kentucky, Department of Radiation, Lexington, KY, USA.
Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):711-7. doi: 10.1016/s0360-3016(01)01676-5.
To evaluate neurocognitive outcome as measured by the Mini-Mental Status Examination (MMSE) among patients with unresectable brain metastases randomly assigned to accelerated fractionation (AF) vs. accelerated hyperfractionated (AH) whole-brain radiation therapy (WBRT).
The Radiation Therapy Oncology Group (RTOG) accrued 445 patients with unresectable brain metastases to a Phase III comparison of AH (1.6 Gy b.i.d. to 54.4 Gy) vs. AF (3 Gy q.d. to 30 Gy). All had a KPS of >or= 70 and a neurologic function status of 0-2. Three hundred fifty-nine patients had MMSEs performed and were eligible for this analysis. Changes in the MMSE were analyzed according to criteria previously defined in the literature.
The median survival was 4.5 months for both arms. The average change in MMSE at 2 and 3 months was a drop of 1.4 and 1.1, respectively, in the AF arm as compared to a drop of 0.7 and 1.3, respectively, in the AH arm (p = NS). Overall, 91 patients at 2 months and 23 patients at 3 months had both follow-up MMSE and computed tomography/magnetic resonance imaging documentation of the status of their brain metastases. When an analysis was performed taking into account control of brain metastases, a significant effect on MMSE was observed with time and associated proportional increase in uncontrolled brain metastases. At 2 months, the average change in MMSE score was a drop of 0.6 for those whose brain metastases were radiologically controlled as compared to a drop of 1.9 for those with uncontrolled brain metastases (p = 0.47). At 3 months, the average change in MMSE score was a drop of 0.5 for those whose brain metastases were radiologically controlled as compared to a drop of 6.3 for those with uncontrolled brain metastases (p = 0.02).
Use of AH as compared to AF-WBRT was not associated with a significant difference in neurocognitive function as measured by MMSE in this patient population with unresectable brain metastases and limited survival. However, control of brain metastases had a significant impact on MMSE.
在随机分配接受加速分割(AF)与加速超分割(AH)全脑放疗(WBRT)的不可切除脑转移瘤患者中,评估通过简易精神状态检查表(MMSE)测量的神经认知结果。
放射肿瘤学组(RTOG)招募了445例不可切除脑转移瘤患者,进行AH(每日两次,每次1.6 Gy,共54.4 Gy)与AF(每日一次,每次3 Gy,共30 Gy)的III期比较。所有患者的KPS评分≥70,神经功能状态为0 - 2。359例患者进行了MMSE评估并符合本分析条件。根据先前文献中定义的标准分析MMSE的变化。
两组的中位生存期均为4.5个月。AF组在2个月和3个月时MMSE的平均变化分别下降1.4和1.1,而AH组分别下降0.7和1.3(p =无显著性差异)。总体而言,2个月时91例患者和3个月时23例患者有MMSE随访以及脑转移瘤状态的计算机断层扫描/磁共振成像记录。在考虑脑转移瘤控制情况进行分析时,观察到随着时间推移对MMSE有显著影响,且未控制的脑转移瘤成比例增加。2个月时,脑转移瘤经放射学控制的患者MMSE评分平均下降0.6,而脑转移瘤未得到控制的患者下降1.9(p = 0.47)。3个月时,脑转移瘤经放射学控制的患者MMSE评分平均下降0.5,而脑转移瘤未得到控制的患者下降6.3(p = 0.02)。
在这群不可切除脑转移瘤且生存期有限的患者中,与AF - WBRT相比,使用AH在通过MMSE测量的神经认知功能方面无显著差异。然而,脑转移瘤的控制对MMSE有显著影响。